Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.31 |
| ▸ | PRKCG | P05129 | 1/20 | 0.31 |
| ▸ | PRKCB | P05771 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 1/20 | 0.31 |
| ▸ | PRKCH | P24723 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15028761 | 1.00 | ALDH1A1 (0.42) | ALDH1A1HTTMEN1THRBKMT2A | |
| SCHEMBL3349172 | 1.00 | ALDH1A1 (0.42) | ALDH1A1HTTMEN1THRBKMT2A | |
| SCHEMBL29314964 | 1.00 | ALDH1A1 (0.42) | ALDH1A1HTTMEN1THRBKMT2A | |
| SCHEMBL5956557 | 0.97 | — | — | |
| SCHEMBL31021559 | 0.92 | THRB (0.41) | ALDH1A1HTTMEN1THRBKMT2A | |
| SCHEMBL28983025 | 0.91 | ALDH1A1 (0.43) | ALDH1A1HTTTHRBTDP1HPGD | |
| SCHEMBL5344 | 0.91 | — | — | |
| SCHEMBL25829986 | 0.89 | MEN1 (0.44) | ALDH1A1HTTMEN1THRBKMT2A | |
| SCHEMBL29928454 | 0.89 | MEN1 (0.44) | ALDH1A1HTTMEN1THRBKMT2A | |
| SCHEMBL18544635 | 0.89 | MEN1 (0.44) | ALDH1A1HTTMEN1THRBKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025110797-A1 | BATTERY MODULE HAVING FIRE-EXTINGUISHING LAYER AND BATTERY FIRE BLOCKING STICK | 주식회사 네패스야하드 | 2025-05-30 | — | — | WO | disclosed |
| WO-2025023562-A1 | SECONDARY BATTERY CELL HAVING FIRE EXTINGUISHING LAYER FORMED THEREIN | 주식회사 네패스야하드 | 2025-01-30 | — | — | WO | disclosed |
| US-20240239934-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | TOSOH CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-11767312-B2 | Phthalazinone compound, and preparation method therefor and medical use thereof | GENENTECH, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| EP-4230620-A1 | SUBSTITUTED N-AMINO-N-BENZOIC ACID URACILS, THEIR SALTS AND USE OF SAID COMPOUNDS AS HERBICIDAL AGENTS | Bayer Aktiengesellschaft (DE) | 2023-08-23 | — | — | EP | disclosed |
| US-20230242510-A1 | PHTHALAZINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | SHANGHAI JEMINCARE PHARMACEUTICALS CO LTD (CN) | 2023-08-03 | — | — | US | disclosed |
| US-20230131252-A1 | PHTHALAZINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | SHANGHAI JEYOU PHARMACEUTICAL CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
| US-8768226-B2 | Developer support member, electrophotographic process cartridge and electrophotographic image forming apparatus | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20130028634-A1 | DEVELOPER SUPPORT MEMBER, ELECTROPHOTOGRAPHIC PROCESS CARTRIDGE AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS | CANON KABUSHIKI KAISHA (JP) | 2013-01-31 | — | — | US | disclosed |
| US-8062768-B2 | Compound comprising phenyl pyridine units | GENERAL ELECTRIC COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| US-8062768-B2 | Compound comprising phenyl pyridine units | GENERAL ELECTRIC COMPANY (US) | 2011-11-22 | — | — | US | disclosed |
| US-8039125-B2 | Compound comprising phenyl pyridine units | GENERAL ELECTRIC COMPANY (US) | 2011-10-18 | — | — | US | disclosed |
| US-20090289547-A1 | COMPOUND COMPRISING PHENYL PYRIDINE UNITS | GENERAL ELECTRIC COMPANY (US) | 2009-11-26 | — | — | US | disclosed |
| US-20090289224-A1 | COMPOUND COMPRISING PHENYL PYRIDINE UNITS | GENERAL ELECTRIC COMPANY (US) | 2009-11-26 | — | — | US | disclosed |
| US-3992416-A | 4-Oxa-5-hydroxypolycycloalkenones-(3) | BASF AKTIENGESELLSCHAFT (DT) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090289547-A1 | COMPOUND COMPRISING PHENYL PYRIDINE UNITS | C1S, C3AR1, CRY1 | ALDH1A1 514/4885HTT 2721/4885MEN1 2736/4885 |
| US-11767312-B2 | Phthalazinone compound, and preparation method therefor and medical use thereof | CYP17A1, AR, NR5A1 | ALDH1A1 490/4885HTT 3064/4885MEN1 425/4885 |
| US-20230131252-A1 | PHTHALAZINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | CYP17A1, AR, NR5A1 | ALDH1A1 490/4885HTT 3064/4885MEN1 425/4885 |
| US-20090289224-A1 | COMPOUND COMPRISING PHENYL PYRIDINE UNITS | C1S, C3AR1, CRY1 | ALDH1A1 514/4885HTT 2721/4885MEN1 2736/4885 |
| US-20230242510-A1 | PHTHALAZINONE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | CYP17A1, AR, NR5A1 | ALDH1A1 490/4885HTT 3064/4885MEN1 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.